Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1979 Jun 9;1(6177):1534–1536. doi: 10.1136/bmj.1.6177.1534

Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

R G Henderson, T Wheatley, J English, J Chakraborty, V Marks
PMCID: PMC1599654  PMID: 380747

Abstract

Renal transplant recipients receiving intermittent haemodialysis and kept under normal ward conditions showed appreciable differences in plasma prednisolone concentrations after therapeutic doses of enteric-coated prednisolone tablets. This gross day-to-day variation occurred irrespective of the dosage used. Breakfast given before prednisolone tended to reduce the rate of absorption of the drug, the effect being quantitatively most pronounced with large doses. Haemodialysis had no apparent effect on the elimination of prednisolone from plasma. Such erratic blood concentrations of prednisolone as observed in these patients, possibly resulting from variable absorption, may be potentially hazardous. Hence use of enteric-coated tablets in renal transplant recipients should be viewed with caution.

Full text

PDF
1535

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hulme B., James V. H., Rault R. Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol. 1975 Aug;2(4):317–320. doi: 10.1111/j.1365-2125.1975.tb02777.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Meikle A. W., Weed J. A., Tyler F. H. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays. J Clin Endocrinol Metab. 1975 Oct;41(4):717–721. doi: 10.1210/jcem-41-4-717. [DOI] [PubMed] [Google Scholar]
  3. Morrison P. J., Bradbrook I. D., Rogers H. J. Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique. Br J Clin Pharmacol. 1977 Oct;4(5):597–603. doi: 10.1111/j.1365-2125.1977.tb00792.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. SANDBERG A. A., SLAUNWHITE W. R., Jr Differences in metabolism of prednisolone-C14 and cortisol-C14. J Clin Endocrinol Metab. 1957 Sep;17(9):1040–1050. doi: 10.1210/jcem-17-9-1040. [DOI] [PubMed] [Google Scholar]
  5. Sherlock J. E., Letteri J. M. Effect of hemodialysis on methylprednisolone plasma levels. Nephron. 1977;18(4):208–211. doi: 10.1159/000180830. [DOI] [PubMed] [Google Scholar]
  6. Uribe M., Schalm S. W., Summerskill W. H., Go V. L. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone. Gastroenterology. 1976 Aug;71(2):362–364. [PubMed] [Google Scholar]
  7. WEST H. F. Prevention of peptic ulceration during corticosteroid therapy. Br Med J. 1959 Oct 10;2(5153):680–680. doi: 10.1136/bmj.2.5153.680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wilson C. G., May C. S., Paterson J. W. Plasma prednisolone levels in man following administration in plain and enteric-coated forms. Br J Clin Pharmacol. 1977 Jun;4(3):351–355. doi: 10.1111/j.1365-2125.1977.tb00723.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES